[A concept of therapy oriented to pathophysiology. Calcium antagonists increase hypoxia tolerance].
D000818:Animals; D002545:Brain Ischemia / Q000188:drug therapy*; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002936:Cinnarizine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005444:Flunarizine; D006801:Humans; D007473:Ion Channels / Q000187:drug effects
D002121:Calcium Channel Blockers; D007473:Ion Channels; D002936:Cinnarizine; D005444:Flunarizine; D002118:Calcium
Ein Therapiekonzept orientiert sich an der Pathophysiologie. Kalzium-Antagonisten erhöhen Hypoxietoleranz.